Advanced Development of Antibacterial Countermeasures
Advanced Development of Antibacterial Countermeasures
抗菌对策的先进发展
批准号：
10787969
负责人：
TROY LISTER
金额：
$149.46万
依托单位：
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
项目状态：
未结题
起止时间：
2021-05-17 至 2025-04-25
关键词：
AddressAdvanced DevelopmentAnti-Bacterial AgentsAntibiotic ResistanceChemistryClinicalDevelopmentGram-Negative BacteriaPathway interactionsbacterial resistanceefficacy evaluationmanufacturenovel therapeuticsphase I trialpre-clinicalproduct developmentresearch and developmentresearch clinical testingsafety assessmenttherapeutic candidate
中文摘要
翻译
支持包括生物防御性病原体在内的抗菌药耐药性候选药物的进一步开发。将支持的研究和开发活动将允许候选治疗产品在产品开发过程中取得进展，包括临床前和IND支持开发活动、化学优化/开发、GMP制造以及临床安全性和有效性评估。
英文摘要
To support the advanced development of a promising candidate therapeutic for antibacterial resistance, including biodefense pathogens. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advanced Development of Antibacterial Countermeasures
-
批准号：10410065
-
项目类别：
-
资助金额：$208.98万
-
财政年份：2021
-
负责人：TROY LISTER
-
依托单位：
海外基金
